These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 28650479)

  • 1. AML1-ETO requires enhanced C/D box snoRNA/RNP formation to induce self-renewal and leukaemia.
    Zhou F; Liu Y; Rohde C; Pauli C; Gerloff D; Köhn M; Misiak D; Bäumer N; Cui C; Göllner S; Oellerich T; Serve H; Garcia-Cuellar MP; Slany R; Maciejewski JP; Przychodzen B; Seliger B; Klein HU; Bartenhagen C; Berdel WE; Dugas M; Taketo MM; Farouq D; Schwartz S; Regev A; Hébert J; Sauvageau G; Pabst C; Hüttelmaier S; Müller-Tidow C
    Nat Cell Biol; 2017 Jul; 19(7):844-855. PubMed ID: 28650479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RUNX1/AML1 DNA-binding domain and ETO/MTG8 NHR2-dimerization domain are critical to AML1-ETO9a leukemogenesis.
    Yan M; Ahn EY; Hiebert SW; Zhang DE
    Blood; 2009 Jan; 113(4):883-6. PubMed ID: 19036704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. snoRNAs contribute to myeloid leukaemogenesis.
    Khalaj M; Park CY
    Nat Cell Biol; 2017 Jun; 19(7):758-760. PubMed ID: 28659642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of AML1-ETO cellular dysregulation correlates with increased leukemogenic potential.
    DeKelver RC; Yan M; Ahn EY; Shia WJ; Speck NA; Zhang DE
    Blood; 2013 May; 121(18):3714-7. PubMed ID: 23426948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A stable transcription factor complex nucleated by oligomeric AML1-ETO controls leukaemogenesis.
    Sun XJ; Wang Z; Wang L; Jiang Y; Kost N; Soong TD; Chen WY; Tang Z; Nakadai T; Elemento O; Fischle W; Melnick A; Patel DJ; Nimer SD; Roeder RG
    Nature; 2013 Aug; 500(7460):93-7. PubMed ID: 23812588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RUNX1-ETO induces a type I interferon response which negatively effects t(8;21)-induced increased self-renewal and leukemia development.
    DeKelver RC; Lewin B; Weng S; Yan M; Biggs J; Zhang DE
    Leuk Lymphoma; 2014 Apr; 55(4):884-91. PubMed ID: 23772668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant transcriptional regulation of the MLL fusion partner EEN by AML1-ETO and its implication in leukemogenesis.
    Ma LH; Liu H; Xiong H; Chen B; Zhang XW; Wang YY; Le HY; Huang QH; Zhang QH; Li BL; Chen Z; Chen SJ
    Blood; 2007 Jan; 109(2):769-77. PubMed ID: 16990610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting miR-193a-AML1-ETO-β-catenin axis by melatonin suppresses the self-renewal of leukaemia stem cells in leukaemia with t (8;21) translocation.
    Zhou B; Ye H; Xing C; Liang B; Li H; Chen L; Huang X; Wu Y; Gao S
    J Cell Mol Med; 2019 Aug; 23(8):5246-5258. PubMed ID: 31119862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Definition of a small core transcriptional circuit regulated by AML1-ETO.
    Stengel KR; Ellis JD; Spielman CL; Bomber ML; Hiebert SW
    Mol Cell; 2021 Feb; 81(3):530-545.e5. PubMed ID: 33382982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AML1/ETO induces self-renewal in hematopoietic progenitor cells via the Groucho-related amino-terminal AES protein.
    Steffen B; Knop M; Bergholz U; Vakhrusheva O; Rode M; Köhler G; Henrichs MP; Bulk E; Hehn S; Stehling M; Dugas M; Bäumer N; Tschanter P; Brandts C; Koschmieder S; Berdel WE; Serve H; Stocking C; Müller-Tidow C
    Blood; 2011 Apr; 117(16):4328-37. PubMed ID: 21245488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between AML1-ETO and MLL-AF9 fusion gene expressions and hematological parameters in acute myeloid leukemia.
    Muddathir ARM; Hamid TAM; Mohamed Elamin E; Khabour OF
    Gulf J Oncolog; 2020 Sep; 1(34):65-69. PubMed ID: 33431365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MEIS2 Is an Oncogenic Partner in AML1-ETO-Positive AML.
    Vegi NM; Klappacher J; Oswald F; Mulaw MA; Mandoli A; Thiel VN; Bamezai S; Feder K; Martens JHA; Rawat VPS; Mandal T; Quintanilla-Martinez L; Spiekermann K; Hiddemann W; Döhner K; Döhner H; Stunnenberg HG; Feuring-Buske M; Buske C
    Cell Rep; 2016 Jul; 16(2):498-507. PubMed ID: 27346355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of CD200R1 in lineage-negative leukemic cells is characteristic of AML1-ETO-positive leukemia in mice.
    Kagiyama Y; Kitaura J; Togami K; Uchida T; Inoue D; Matsukawa T; Izawa K; Kawabata KC; Komeno Y; Oki T; Nakahara F; Sato K; Aburatani H; Kitamura T
    Int J Hematol; 2012 Nov; 96(5):638-48. PubMed ID: 23097187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-intrinsic depletion of Aml1-ETO-expressing pre-leukemic hematopoietic stem cells by K-Ras activating mutation.
    Di Genua C; Norfo R; Rodriguez-Meira A; Wen WX; Drissen R; Booth CAG; Povinelli B; Repapi E; Gray N; Carrelha J; Kettyle LM; Jamieson L; Neo WH; Thongjuea S; Nerlov C; Mead AJ
    Haematologica; 2019 Nov; 104(11):2215-2224. PubMed ID: 30975913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PLCG1 is required for AML1-ETO leukemia stem cell self-renewal.
    Schnoeder TM; Schwarzer A; Jayavelu AK; Hsu CJ; Kirkpatrick J; Döhner K; Perner F; Eifert T; Huber N; Arreba-Tutusaus P; Dolnik A; Assi SA; Nafria M; Jiang L; Dai YT; Chen Z; Chen SJ; Kellaway SG; Ptasinska A; Ng ES; Stanley EG; Elefanty AG; Buschbeck M; Bierhoff H; Brodt S; Matziolis G; Fischer KD; Hochhaus A; Chen CW; Heidenreich O; Mann M; Lane SW; Bullinger L; Ori A; von Eyss B; Bonifer C; Heidel FH
    Blood; 2022 Feb; 139(7):1080-1097. PubMed ID: 34695195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AML1-ETO mediates hematopoietic self-renewal and leukemogenesis through a COX/β-catenin signaling pathway.
    Zhang Y; Wang J; Wheat J; Chen X; Jin S; Sadrzadeh H; Fathi AT; Peterson RT; Kung AL; Sweetser DA; Yeh JR
    Blood; 2013 Jun; 121(24):4906-16. PubMed ID: 23645839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRMT1 interacts with AML1-ETO to promote its transcriptional activation and progenitor cell proliferative potential.
    Shia WJ; Okumura AJ; Yan M; Sarkeshik A; Lo MC; Matsuura S; Komeno Y; Zhao X; Nimer SD; Yates JR; Zhang DE
    Blood; 2012 May; 119(21):4953-62. PubMed ID: 22498736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The leukemia associated nuclear corepressor ETO homologue genes MTG16 and MTGR1 are regulated differently in hematopoietic cells.
    Ajore R; Kumar P; Dhanda RS; Gullberg U; Olsson I
    BMC Mol Biol; 2012 Mar; 13():11. PubMed ID: 22443175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of c-Myb with p300 is required for the induction of acute myeloid leukemia (AML) by human AML oncogenes.
    Pattabiraman DR; McGirr C; Shakhbazov K; Barbier V; Krishnan K; Mukhopadhyay P; Hawthorne P; Trezise A; Ding J; Grimmond SM; Papathanasiou P; Alexander WS; Perkins AC; Levesque JP; Winkler IG; Gonda TJ
    Blood; 2014 Apr; 123(17):2682-90. PubMed ID: 24596419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.